Clinical Trial: Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385808) titled 'Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML' on April 23.

Brief Summary: The primary objective of this study was to evaluate the efficacy of MTBF conditioning regimen of salvageable allo-HSCT in patients with relapsed or refractory acute myeloid leukemia. The secondary purpose of the study was to observe the safety of MTBF regimen in these patients.

Study Type: Interventional

Condition: * Relapse Leukemia

* Refractory Acute Myeloid Leukemia

* Conditioning

* Hematopoietic Stem Cell Transplantation

Intervention: Drug: MTBF regimen

The subjects will be treated with mito...